First biosimilar insulin launches

Abasaglar is a new biosimilar version of the long-acting insulin glargine (Lantus).

KwikPen delivers 1 to 60 units of insulin in single-unit increments.
KwikPen delivers 1 to 60 units of insulin in single-unit increments.

Further information
View Abasaglar drug record
Summary of Product Characteristics
Manufacturer: Eli Lilly

Like Lantus, Abasaglar is given once daily and is licensed for use in patients from the age of 2 years. It is available as a prefilled KwikPen or as cartridges for use in the reusable HumaPen and Autopen Classic devices.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases